Medical Innovation Exchange

diagnostics

AI’s Ability to Detect Tumor Cells Could be Key to More Accurate Bone Cancer Prognoses

AI’s Ability to Detect Tumor Cells Could be Key to More Accurate Bone Cancer Prognoses     Press Release: MTI Staff was not involved in writing this content April 2, 2023 / Kyushu, Fukuoka, Japan – Researchers at Kyushu University have developed and validated a machine-learning model that can accurately evaluate the density of surviving tumor …

AI’s Ability to Detect Tumor Cells Could be Key to More Accurate Bone Cancer Prognoses Read More »

Breath-based Analysis: Revolutionizing Disease Screening for a Healthier Tomorrow

Breath-based Analysis: Revolutionizing Disease Screening for a Healthier Tomorrow     Despite significant progress in disease testing methodologies, notable deficiencies persist. Misdiagnosis, characterized by the detection of false positives, is prevalent across various screening procedures. Moreover, many severe illnesses currently require expensive, invasive tests that are frequently inaccessible to patients. Compounding the issue, certain diseases with …

Breath-based Analysis: Revolutionizing Disease Screening for a Healthier Tomorrow Read More »

Hologic AI-Based Genius Diagnostics System Enters U.S. Market

Hologic AI-Based Genius Diagnostics System Enters U.S. Market     In February, the FDA granted marketing clearance of the Hologic Genius Digital Diagnostics System, which uses deep learning-based artificial intelligence (AI) and advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells. The system, which scans cytology slides to create digital images, and then …

Hologic AI-Based Genius Diagnostics System Enters U.S. Market Read More »

How AI Can Advance Breast Cancer Detection and Treatment

How AI Can Advance Breast Cancer Detection and Treatment     In recent years, the synergy between technology and healthcare has ushered in an era of unprecedented progress, reshaping the landscape of disease detection and treatment in ways previously deemed unimaginable. Among the myriad of ailments, breast cancer stands as a formidable adversary, affecting women and …

How AI Can Advance Breast Cancer Detection and Treatment Read More »

The Role of Computational Simulation in Modeling Fluidic-based Cassettes for POC Devices

The Role of Computational Simulation in Modeling Fluidic-based Cassettes for POC Devices     The rising incidence of infectious diseases has acted as a driving force for the accelerated development of precise, decentralized and cost-effective diagnostic technologies. Within this landscape, point-of-care (POC) devices stand out as game-changing instruments, capable of delivering quick and accurate diagnoses right …

The Role of Computational Simulation in Modeling Fluidic-based Cassettes for POC Devices Read More »

Precision Medicine Meets AI: Advances in Cough Monitoring

Precision Medicine Meets AI: Advances in Cough Monitoring     Cough is a common and, at times, problematic medical condition that is ripe for disruption. It is one of the main reasons why patients seek medical care. In Europe and the U.S., between 9% and 33% of the population reports cough at any given time; and …

Precision Medicine Meets AI: Advances in Cough Monitoring Read More »

Veranex Acquires Fusion Biotec

Veranex Acquires Fusion Biotec     Global, tech-enabled service provider to the MedTech industry Veranex has acquired Fusion Biotec, a design and engineering firm for complex electro-mechanical diagnostic instrumentation and medical devices located in Orange, California. Fusion boasts a 15,000-square-foot facility in Orange, California, and an in-house team of more than 45 engineering experts, who largely serve …

Veranex Acquires Fusion Biotec Read More »

Lace To Helm New RQM+ Reimbursement Division

Lace To Helm New RQM+ Reimbursement Division     RQM+, a global MedTech regulatory and quality service provider, has launched a reimbursement division to provide its clients with reimbursement services, in addition to regulatory, quality, clinical and laboratory services, throughout the medical device and diagnostics product lifecycle. Daniel Lace, MD, will lead the new division and …

Lace To Helm New RQM+ Reimbursement Division Read More »

WHO Convenes Panel to Identify Priority Pathogens for Research and Oversight 

WHO Convenes Panel to Identify Priority Pathogens for Research and Oversight      The World Health Organization (WHO) announced that it is launching a global scientific process to update the list of priority pathogens to guide global investment, research and development of vaccines, tests and treatments. The process began on November 18 with a meeting of …

WHO Convenes Panel to Identify Priority Pathogens for Research and Oversight  Read More »

The Real Impact of IVDR on Clinical Evidence Requirements

The Real Impact of IVDR on Clinical Evidence Requirements     For many manufacturers of IVD devices now on the European market, meeting the evidence required of the EU In Vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR) will require tremendous work. With the shortage of notified bodies and resources, numerous outstanding guidance questions, as well as …

The Real Impact of IVDR on Clinical Evidence Requirements Read More »